Inference for meta-analysis with a suspected temporal trend

Biometrical Journal

Volumn 52, Issue 4, 2010, Pages 538-551

  Baker, Rose ^a   Jackson, Dan ^b  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

Empirical bayes; H likelihood; Meta analysis; Permutation test; Secular trend

Indexed keywords

BAYESIAN NETWORKS; RANDOM PROCESSES;

BAYESIAN METHODS; EMPIRICAL BAYES; FREQUENTIST; H-LIKELIHOOD; META-ANALYSIS; PERMUTATION TESTS; POINT ESTIMATE; SECULAR TREND; TEMPORAL TRENDS; TREATMENT EFFECTS;

SENSITIVITY ANALYSIS;

EID: 77956270849     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200900307     Document Type: Article

References (28)

1. Banks, K., Tuazon, E., Koh, C., De Filippo, R., Chang, A., Berhane, K. and Cortessis, V. K. (2008). Comprehensive meta-analysis of cryptorchidism-testis cancer association reveals a strong secular trend and notable modification by histologic type of tumor. Journal of Urology 179, 7-8.
2. Biggerstaff, B. J. and Tweedie, R. L. (1997). Incorporating variability of estimates heterogeneity in the random effects model in meta-analysis. Statistics in Medicine 16, 753-768.
3. Breslow, N. E. and Clayton, D. G. (1993). Approximate inference in generalized linear mixed models. Journal of the American Statistical Association 88, 9-25.
4. Copas, J. B. and Malley, P. F. (2008). A robust P-value for treatment effect in meta-analysis with publication bias. Statistics in Medicine 27, 4267-4278.
5. DerSimonian, R. and Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-188.
6. Gehr, B. T., Weiss, C. and Porzsolt, F. (2006). The fading of reported effectiveness. A meta-analysis of randomised controlled trials. BMC Medical Research Methodology 6, doi:10.1186/1471-2288-6-25.
7. Haas, S. J., Dennekamp, M. N. and Vos, T. (2006). Beware the meta-analysis-clozapine and suicidal ideation. Schizophrenia Research 86, 331-332.
8. Hennen, J. and Baldessarini, R. J. (2005). Suicidal risk during treatment with clozapine: a meta-analysis. Schizophrenia Research 73, 139-145.
9. Higgins, J. P. T. and Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21, 1539-1558.
10. Higgins, J. P. T. and Thompson, S. G. (2004). Controlling the risk of spurious findings from meta-regression. Statistics in Medicine 23, 1663-1682.
11. Hodgson, M. J., Parkinson, D. K. and Karpf, M. (1989). Chest X-rays in hypersensitivity pneumonitis-a meta-analysis of secular trend. American Journal of Industrial Medicine 16, 45-53.
12. Ioannidis, J. P. A. (2006). Evolution of research findings: from bench to where? Plos Clinical Trials 1, e36. doi:10.1371/journal.pctr.0010036.
13. Ioannidis, J. P. A. and Lau, J. (2001). Evolution of treatment effects over time: Empirical insight from recursive cumulative metaanalyses. Proceedings of the National Academy of Sciences of the United States of America 98, 831-836.
14. Ioannidis, J. P. A., Polycarpou, A., Ntaisa, C. and Pavlidis, N. (2003). Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer: biases and evolution over time. European Journal of Cancer 39, 2278-2287.
15. Jackson, D. (2008). The significance level of meta-regression's standard hypothesis test. Communications in Statistics-Theory and Methods 37, 1576-1590.
16. Jennions, M. D. and Møller, A. P. (2001). Relationships fade with time: a meta-analysis of temporal trends in publication in ecology and evolution. Proceedings of the Royal Society of London B 269, 43-48.
17. Kayande, U. and Bhagarva, M. (1994). An examination of temporal patterns in meta-analysis. Marketing Letters 5, 141-151.
18. Lee, Y. and Nelder, J. A. (1996). Hierarchical generalized linear models (with discussion). Journal of the Royal Statistical Society, Series B 58, 619-678.
19. Lee, Y. and Nelder, J. A. (2002). Analysis of ulcer data using hierarchical generalized linear models. Statistics in Medicine 21, 191-202.
20. Lunn, D. J., Thomas, A., Best, N. and Spiegelhalter, D. (2000). Winbugs-a Bayesian modelling framework: concepts, structure, and extensibility. Statistics in Computing 10, 325-337.
21. Maritz, J. S. and Lwin, T. (1989). Empirical Bayes Methods (2nd edn.) Chapman and Hall, London.
22. Nieuwkamp, D. J., Setz, L. E., Algra, A., Linn, F. H. H., De Rooij, N. K. and Rinkel, G. J. E. (2009). Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. The Lancet Neurology 8, 635-642.
23. O'Hagan, A. and Forster, J. (2004). Kendall's Advanced Theory of Statistics: Volume 2B: Bayesian Inference (2nd edn.), Arnold, London.
24. Senn, S. (1996). Relation between treatment benefit and underlying risk in meta-analysis. Standard of "label invariance" should not be abandoned. British Medical Journal 313, 1550-1551.
25. Thompson, S. G. and Higgins, J. P. T. (2002). How should meta-regression analyses be undertaken and interpreted? Statistics in Medicine 21, 1559-1573.
26. Thompson, S. G. and Sharp, S. J. (1999). Explaining heterogeneity in meta-analysis: a comparison of methods. Statistics in Medicine 18, 2693-2708.
27. Valtkus, P. T. and Brar, C. (2007). N-Acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. American Heart Journal 153, 275-280.
28. Vasicek, O. A. (1973). A note on using cross-sectional information in Bayesian estimation of security betas. Journal of Finance 28, 1233-1239.